Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Roundhill Innov-100 0DTE Covered Call Strat ETF (QDTE) vs UnitedHealth Group Inc (UNH) Price & Performance

Roundhill Innov-100 0DTE Covered Call Strat ETFTrade
UnitedHealth Group IncTrade

Price performance (Past 24H)

Key statistics

Roundhill Innov-100 0DTE Covered Call Strat ETF vs UnitedHealth Group Inc — how do they compare? Roundhill Innov-100 0DTE Covered Call Strat ETF trades at $28.64, while UnitedHealth Group Inc trades at $394.09 (market cap $359.79B). The key difference: UnitedHealth Group Inc pays a 2.32% dividend while Roundhill Innov-100 0DTE Covered Call Strat ETF pays none, and UnitedHealth Group Inc is trading nearer its 52-week high, Roundhill Innov-100 0DTE Covered Call Strat ETF nearer its low. Which is the better fit depends on your goals.

QDTEUNH
Sector
Income / Options OverlayHealth
52-Week High
$36.60$436.35
52-Week Low
$26.85$259.02
Market Cap
$359.79B
Enterprise Value
$401.65B
Dividend Yield
2.32%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Roundhill Innov-100 0DTE Covered Call Strat ETF

QDTE trades at $28.86 with minimal daily movement (+0.07%). The ETF shows bearish technical signals with selling pressure outweighing buying signals 12-4. Recent news highlights concerns about the fund's sustainability as volatility declines and distributions are funded by return of capital, causing NAV erosion. The fund's 0.97% expense ratio consumes significant portions of its weekly payouts.

The outlook remains cautious given structural concerns about the fund's distribution model. While weekly income appeals to investors, the erosion of net asset value and dependence on return of capital present significant risks. Analyst sentiment has turned negative with recent downgrades citing underperformance in bull markets and unsustainable yield mechanics.

UnitedHealth Group Inc

UnitedHealth Group (UNH) trades at $393.06, down 1.03% on the day, with a bullish technical signal from moving averages and strong analyst support. The company reported revenue of $447.57B in 2025, with net income of $12.06B, and has beaten EPS estimates in recent quarters. Recent news highlights strategic moves to reduce pediatric prior authorizations and ongoing shareholder returns via dividends and buybacks.

The outlook for UNH is positive, driven by aging demographics, Medicare growth, and operational efficiencies, though risks include regulatory scrutiny and margin pressures. With 82.7% of analysts rating it a buy and a consensus price target of $475.47, the stock presents a compelling opportunity for long-term investors seeking exposure to healthcare stability and dividend growth.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Roundhill Innov-100 0DTE Covered Call Strat ETF

QDTE is an actively managed ETF that seeks to generate income through a covered call strategy on the NASDAQ 100. It primarily holds a portfolio of U.S. government securities and sells 0-DTE (zero days to expiration) index call options on the NASDAQ 100. This highly tactical strategy aims to maximize option premium capture by exploiting the rapid time decay of options expiring on the same day, which provides enhanced income but also exposes the fund to significant volatility and risks associated with daily options settlement.

Read more on QDTE

About UnitedHealth Group Inc

UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.

Read more on UNH